Atlas Trials

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Clinical trial NCT07069062 · RECRUITING

Trial details

NCT number
NCT07069062
Sponsor
Sichuan Huiyu Pharmaceutical Co., Ltd
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Solid Tumor
Start date
2025-07-21
Primary completion
2027-06-01
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.